Articles by tag: cholesterol

AAV gene therapy for HoFH: cholesterol reduction by 97.5% in clinical trial

New AAV8 gene therapy NGGT006 for homozygous familial hypercholesterolemia reduced LDL-C by 97.5% in 3 weeks. Effect persists for 52 weeks. Find out who is eligible for treatment.

Cholesterol gene therapy VERVE-102: NEJM data, LDL reduction by 62%

NEJM published phase 1b results of gene therapy VERVE-102: LDL reduction by 62% after a single injection. Analysis of efficacy, risks, and prospects for patients with hypercholesterolemia. Read more.